Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
Stock. Additional stock would be great incentive.
Was sind einige der besten Dinge an Ihrem Team?
My team works hard, is dedicated and supportive of one another.
Was gefällt dir am besten am Führungsteam?
The team is nimble and willing to take swift action with matters that affect business.
Was macht Sie bei der Arbeit am glücklichsten?
It’s fulfilling to pull through initiatives and projects successfully. It’s also nice to feel appreciated or recognition for succe
Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?
Executive team is supportive and generally willing to take swift action when needed. Innovation and urgency enable a healthy nimble environment.
Other Employee Reviews for Karyopharm Therapeutics
×